L?Arginine Hydrochloride & Glucose Injection 10?g + 25?g (Kangsikowe)

$2.00

This sterile injection delivers 10?g L?arginine HCl and 25?g glucose per 500?ml bottle. Manufactured by Sichuan Kelun Pharmaceutical Co., Ltd. and approved under NMPA H20040530. Ideal for preclinical studies on hyperammonemia, hepatic encephalopathy, urea cycle disorders, and ammonia metabolism.
?? For laboratory and research use only.?Please consult staff for other specifications and uses?

Compare

描述

L?Arginine HCl combined with glucose supports detoxification by activating the urea cycle, facilitating hepatic ammonia clearance. The glucose portion supplies energy substrates, offsetting the catabolic stress during hepatic dysfunction. Primarily used in animal models of hepatic encephalopathy and acute hyperammonemia to study neuroprotection and detoxification pathways.

Contents hide

1 L?Arginine Hydrochloride & Glucose Product Specifications

2 L?Arginine Hydrochloride & Glucose Mechanism of Action

3 L?Arginine Hydrochloride & Glucose Research Application Areas

4 Safety & Handling

5 Core Keywords

6 Research Use Disclaimer

L?Arginine Hydrochloride & Glucose Product Specifications

Parameter	Details
Product Name	L?Arginine Hydrochloride & Glucose Injection (Kangsikowe)
Active Ingredients	L?Arginine HCl 10?g; Glucose 25?g
CAS Numbers	Arginine HCl: –; Glucose: –
Formulation	Sterile aqueous injection, 500?ml bottle
Strength	10?g + 25?g per 500?ml
Dosage Form	Injection (500?ml infusion)
Approval No.	H20040530
Drug Standard Code	86902180001467
Manufacturer	Sichuan Kelun Pharmaceutical Co., Ltd.
Packaging	500?ml glass bottle × 1
Storage Conditions	Room temperature storage, protect from light and contamination
Intended Use	Lab research: hyperammonemia, hepatic encephalopathy, ammonia detox models

L?Arginine Hydrochloride & Glucose Mechanism of Action

Arginine is a substrate in the urea cycle, converting ammonia into urea. Combined with glucose, it optimizes detoxification and energy supply in acute liver injury and ammonia metabolism. This formulation is used in models of hepatic encephalopathy and urea cycle dysfunction.

L?Arginine Hydrochloride & Glucose Research Application Areas

Hepatic encephalopathy models: ammonia detox via urea cycle
Hyperammonemia studies
Ammonia metabolism & neuroprotection assays
Glucose support in liver failure models

Safety & Handling

Dosage in models: 15–20?g arginine IV over 4 hours for ammonia-lowering studies
Side Effects: Generally mild; monitor glucose and electrolytes.
Contraindications: Sodium-sensitive conditions, severe hyperglycemia, arginine hypersensitivity.
Storage: Keep sealed at room temperature, away from light.
Handling: Use under lab protocols with standard aseptic technique.

Core Keywords

L-arginine glucose injection, arginine HCl glucose 10g+25g, ammonia detox injection, hyperammonemia research, hepatic encephalopathy model, H20040530, lab-grade arginine glucose infusion

Research Use Disclaimer

This product is intended exclusively for laboratory and preclinical research use. It is not approved for clinical, therapeutic, diagnostic, or veterinary use. Misuse may pose health or regulatory risks. Use only under institutional protocols.

其他信息

重量	1.2 公斤
尺寸	28 × 23 × 28 厘米

评价

目前还没有评价

成为第一个“L?Arginine Hydrochloride & Glucose Injection 10?g + 25?g (Kangsikowe)” 的评价者